Back to top Open menu arrow
Download PDF Reprints

The Journal of
Clinical Psychiatry
Free access

The Journal of Clinical Psychiatry

Letter to the Editor October 15, 1998

Reply to Letter to the Editor "Olanzapine and Negative Symptoms"

; ; ; ; ;

J Clin Psychiatry 1998;59(10):537-537

Article Abstract

Sir: We appreciate Dr. Rosen’s interesting report of the efficacy of olanzapine in relieving chronic negative symptoms resistant to risperidone in a patient with schizoaffective disorder, bipolar type. His letter emphasizes several points that are in agreement with emerging data regarding the clinical utility of olanzapine.

Also from JCP

Dr Michael Asbach on the Evolution of PAs in Psychiatry From Academia to Industry: Dr. Stephen Brannan’s Journey in Shaping Modern Mental Health Care The Mission of JCP with Editor-in-Chief Marlene P. Freeman, MD

From the Editors

New Series The JCP Podcast Insightful, evidence-based conversations on the latest in psychiatric care — from the editors of JCP.

 

About the Authors

This PDF is free for all visitors!

Vol 87 • 2026 • Number 1

Read the Current Issue

ASCP Corner

Rethinking Amisulpride: Could N-Methylation Result in a New and Even Better Antipsychotic?

Original Research

How Many Criteria Should be Required to Define the DSM-5 Mixed Features Specifier in Depressed Patients?

Meta-Analysis

Effectiveness of Peer-Administered Interventions for Perinatal Depression or Anxiety

Original Research

Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024

Brief Report

Exercise Reduces Dysphoria in Clinical High-Risk for Psychosis: A Randomized Controlled Trial

Clinical and Practical Psychopharmacology

Pregabalin in Pregnancy: Major Congenital Malformations, Other Birth Outcomes, and Neurodevelopmental Outcomes
View current Issue

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe